News

You are here

May 07, 2012

Iproteos has been selected as one of the finalists presenting their business project at the BIOCHEM Accelerator Forum, which takes place next June in Frankfurt during the ACHEMA 2012 fair in the frame of the BiobasedWorld

http://www.biochem-project.eu/index.php?page=accelerator/frankfurt

May 07, 2012

Iproteos is mentioned in the El Periódico monographic supplement "Impulso empresarial" from April 27th 2012 El Periodico Supplement Newspaper

May 04, 2012

Iproteos is present at the 7th International Symposium on Neuroprotection and Neurorepair 2012 in Potsdam (Germany) from May 2nd to May 5th, joining experts in the field of stroke as well as Parkinson’s and  Alzheimer’s disease to discuss recent scientific findings.

Jan 23, 2012

Iproteos founder Prof. Ernest Giralt was awarded the National Research Award 2011 by the Spanish Ministry of Science. He was recognized in the category of Science and Technology for his contributions to the design, synthesis, controlled modification and structure of peptides and proteins, as well as for his contributions to advancing the study of the function of proteins involved in the development of Alzheimer’s disease and schizophrenia, and more recently for the use of peptides in nanobiotechnology to create remote-controlled drugs.

Jan 23, 2012

Iproteos, among the 31 new technological spin-off companies launched in 2011 with support from ACC1Ó, the agency set up by the Catalan Government to promote competitiveness among enterprises. ACC1Ó fosters the establishment and growth of new technology-based companies in Catalonia, enabling technology transfer from basic research and universities into the business world.

Dec 04, 2011

The scientists of Iproteos will attend the workshop organized by the European Federation for Medicinal Chemistry (EFMC) in Oegsteest (The Netherlands), which will be focused on the current safety and toxicity tests carried out in pre-clinical and clinical stages.